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AbstrAct
Introduction Reduced health-related quality of life 
(HRQOL) has been reported in postoperative patients with 
congenital heart disease (CHD). However, there is a paucity 
of data from low-income and middle-income countries 
(LMIC). Differences in sociodemographics and sociocultural 
contexts may influence HRQOL. This protocol paper 
describes a study exploring HRQOL in surgical patients 
with CHD from a tertiary hospital in Pakistan. The study 
findings will assist development of strategies to improve 
HRQOL in a resource-constrained context.
Methods and analysis This prospective, concurrent 
triangulation, mixed-methods study aims to compare 
HRQOL of postsurgery patients with CHD with  
age-matched healthy siblings and to identify HRQOL 
predictors. A qualitative component aims to further 
understand HRQOL data by exploring the experiences 
related to CHD surgery for patients and parents. 
Participants include patients with CHD (a minimum of 
n~95) with at least 1-year postsurgery follow-up and no 
chromosomal abnormality, their parents and age-matched, 
healthy siblings. PedsQL 4.0 Generic Core Scales, PedsQL 
Cognitive Functioning Scale and PedsQL 3.0 Cardiac 
Module will measure HRQOL. Clinical/surgical data will be 
retrieved from patients’ medical files. Student’s t-test will 
be used to compare the difference in the means of HRQOL 
between CHD and siblings. Multiple regression will identify 
HRQOL predictors. A subsample of enrolled patients 
(n~20) and parents (n~20) from the quantitative arm 
will be engaged in semistructured qualitative interviews, 
which will be analysed using directed content analysis. 
Anticipated challenges include patient recruitment due 
to irregular follow-up compliance. Translation of data 
collection tools to the Urdu language and back-translation 
of interviews increases the study complexity.
Ethics and dissemination Ethics approval has been 
obtained from The Aga Khan University, Pakistan 
(3737-Ped-ERC-15). Study findings will be published in 
peer-reviewed journals and presented at national and 
international conferences.
IntroductIon
Childhood is a critical period in growth and 
development, forming the basis for healthy 
adult life. Therefore, when congenital 
conditions such as congenital heart disease 
(CHD) occur, there is the potential for 
substantial impact across the lifespan, espe-
cially given that almost 90% of patients with 
CHD survive until adulthood.1 2 Though 
advancement in medical and surgical manage-
ment has decreased mortality and increased 
survival, the majority of CHD surgical proce-
dures are palliative, improving symptoms, but 
leaving residual issues such as arrhythmias, 
heart failure, protein enteropathy, poten-
tial for further operations and pacemaker 
insertion.3 
Health-related quality of life (HRQOL) is 
an important consideration for patients with 
CHD following surgery as routine clinical 
measurements may not always truly reflect 
the disease symptoms, treatment burden, 
functional limitations or the need for adjust-
ment to disability that a person may expe-
rience. HRQOL is complex as it requires 
understanding of an individual’s perception 
and experiences of their health-related issues 
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Protocol
strengths and limitations of the study
 ► First study of its kind exploring health-related quality 
of life  (HRQOL) in surgical patients with congenital 
heart disease (CHD) through a mixed-methods 
approach in one of the low-income  and middle-
income countries.
 ► Qualitative assessment of the study will help identify 
unique, contextual sociodemographic HRQOL issues 
in patients with CHD.
 ► Comparison of the HRQOL of patients with CHD with 
their age-matched siblings will control a number of 
potential confounders that could influence the study 
findings.
 ► Quality of life questionnaires will be used in the 
study setting for the first time; hence, there could be 
cross-cultural bias.
 ► Patient recruitment from a single centre might limit 
the generalisability of the study findings.
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Figure 1 Revised Wilson and Cleary model for health-related quality of life.
and their perceived level of adaptation and coping. Addi-
tionally, it is strongly suggested that HRQOL be assessed 
by using both generic and disease-specific questionnaires.4
As a research tool, HRQOL assessments in CHD provide 
validated measures of functional data that correlate with 
findings from standardised clinical assessment tools.5 
In addition, HRQOL provides a good benchmark for 
assessing the benefit of surgical and other therapeutic 
interventions and reveals where the best patient-sensitive 
gains can be made.
As a clinical tool, assessment of HRQOL provides 
important data on individual patients’ current health 
status. Poor HRQOL findings reflect poor functional 
status that, in turn, impacts on patients’ quality-adjusted 
life years (QALYs). Poor HRQOL also results in higher 
utilisation of healthcare services6 and may lead to later 
difficulties in securing and maintaining employment.7 
For these reasons, HRQOL screening should be routine 
in CHD populations and is recommended by the Centers 
for Disease Control and Prevention8 and the American 
Heart Association.9
Uptake of routine HRQOL screening has been slow, 
and this may be due to clinicians’ beliefs about availability 
and usability of screening tools, methodological concerns 
and pragmatic considerations, the latter being addressed 
by more recent electronic formats.10 A lack of HRQOL 
monitoring that reveals patient and parent perspectives to 
practitioners misses an opportunity for crucial collabora-
tive development of a patient-centred care plan that may 
enhance adherence to treatment recommendations.11 
HRQOL screening in diverse clinical settings has led to 
more frequent quality of life (QOL) discussions between 
patients and clinicians, including symptoms, function 
in activities of daily living and treatment satisfaction,10 
and such discussions may provide the basis for increased 
psychological support.12
While survival of patients with CHD has improved, a number 
of studies from high-income countries have reported lower 
overall HRQOL in surgical patients with CHD compared with 
normal cohorts.13 14 These are expressed in multiple domains 
including physical,13–16 motor,17 emotional,14–18 social,14 15 17 18 
school,14 15 cognitive and psychosocial functioning13–15 in 
both patients’ and parents’ reports. When critiqued using the 
Newcastle-Ottowa Scale for Cross-sectional Studies19 and Gill 
and Feinstein’s 10 criteria for evaluating HRQOL research,20 
CHD HRQOL reports are generally strong in their applica-
tion of rigorous statistical methods, use of a control group 
and their representativeness for the target population. 
Limitations include conceptual definition of HRQOL used, 
providing opportunity for patients to highlight HRQOL 
domains important to them, and poor justification for the 
sample sizes used.14 16 21–23 This body of work has also been 
criticised for lack of conceptual rigour and poor attention to 
reporting of inclusion criteria.24
There is some evidence that the presence of resources 
such as having educated parents,25 living with family and 
having higher socioeconomic status22 is associated with 
better HRQOL of patients with CHD. While these avail-
able resources are important contributors to QOL in 
CHD, a crucial consideration in HRQOL is the extent of 
the underlying disease and the impact of related symp-
toms. This is well illustrated in the Wilson and Cleary 
model of HRQOL (modified by Ferrans et al)26 (figure 1). 
Based on this theoretical model, this study will explore 
the relationship of biological function, symptoms, func-
tional status and general health perception along with 
the individual and environmental characteristics or the 
available resources with HRQOL.
The influence of resource availability on HRQOL suggests 
that study findings on CHD surgical outcomes conducted 
in high-income countries (HIC) are likely to differ from 
those conducted in low-income and middle-income coun-
tries (LMIC). For example, in Pakistan, more than 50% of 
the population fall below the poverty line and literacy rates 
are low at 60%. This mismatch is a problem because CHD is 
common in LMIC where birth rates are high.27
The number of people with CHD can be difficult to 
characterise because the terminologies of incidence and 
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prevalence are often used interchangeably.27 CHD varies 
across continents, with Asia having the highest CHD inci-
dence of 9.3/1000 live births.28 While incidence is often 
similar across continents, prevalence varies, depending 
on fertility and birth rates. Inferring Asian CHD incidence 
to Pakistan, it is estimated that 50 000 children with CHD 
are born every year in the country.29 The true prevalence 
may be higher because of the incomplete data registry.
Pakistan has a lack of resources for health provision, 
where for a population of 180 million, there are only 
5 hospitals providing paediatric cardiology services, 
25 paediatric cardiologists and 8 paediatric cardiac 
surgeons.30 Adding to the difficulty in providing health 
services, 62% of the population lives in rural areas where 
accessibility, availability and affordability issues lead to 
late diagnosis, referral and surgery as well as difficulties 
with CHD follow-up.31–33 At times, families sacrifice their 
jobs and sell their assets to enable their child to have 
life-saving surgery for CHD.34 Therefore, it is essential 
to investigate HRQOL following CHD surgery in this 
context, to identify needs and arrange for optimal and 
targeted support within the available resources.
We were unable to find literature on HRQOL for 
patients with CHD from LMIC. This represents a major 
gap in our understanding for this population. Consid-
ering the differences in sociodemographics and the 
impact of constrained resources on late presentation 
and surgery, HRQOL may differ according to a country’s 
economic status. The scarce literature available on CHD 
outcomes from LMIC does not explore QOL or long-
term outcomes and, rather, focuses on 30-day mortality 
and initial surgical outcomes.33 35–38 This is problematic, 
given that CHD is a disease requiring life-long care, and 
surgery is palliative rather than curative.39 In routine clin-
ical practice, patients identified at high risk of long-term, 
poor HRQOL provide a smaller, targeted population 
for more costly evaluation measures (eg, neurocognitive 
testing and cardiac imaging). HRQOL screening there-
fore has potential to inform more cost-effective care plan-
ning and, in turn, to increase QALYs.
Given the contextual differences between HIC and 
LMIC such as Pakistan, it is crucial that the HRQOL of 
this population is compared with an appropriate group. 
In this case, age-matched healthy siblings are ideal 
because of the shared sociodemographics controlling for 
a number of confounding factors.40 41 Furthermore, an 
insight into parents’ and children’s experiences following 
CHD surgery will provide essential information to help 
develop appropriate processes for care that respond to 
the specific context.
This study intends to determine HRQOL for people 
following CHD surgery compared with age-matched 
healthy siblings. It also strives to identify predictors of 
HRQOL in surgical patients with CHD. Additionally, we 
will describe the everyday experiences of patients and 
families after CHD surgery to illuminate our quantitative 
findings. The study findings will provide an important 
benchmark against which future efforts may be compared, 
within individual countries and across countries interna-
tionally. We do expect to see some differences in HRQOL 
in the Pakistani setting compared with results from HIC. 
If this study can detect and explain these differences, 
then it is indeed adding value to the pre-existing litera-
ture and highlights the need of conducting work that is 
contextual. In addition, the qualitative arm of the study 
will help us identify contextual modifiers of HRQOL in 
patients with CHD in a country like Pakistan.
MEthods
Aim
This paper aims to describe the study methodology to 
explore the HRQOL in postoperative patients with CHD 
in Pakistan.
research questions
The study aims to address the following research 
questions:
In a tertiary care hospital in Pakistan following CHD 
surgery:
1. What is the HRQOL in patients with CHD compared 
with their age-matched sibling?
2. What are the predictors (preoperative, intraoperative, 
postoperative, postdischarge and sociodemographics) 
of HRQOL in patients with CHD?
3. What are the experiences of patients with CHD and 
their parent, related to surgery, recovery and living 
with CHD?
study design
The study uses the convergence model of a concurrent 
triangulation mixed-methods design,42 which has been 
recommended for outcomes research.43 This includes 
quantitative and qualitative approaches that comple-
ment each other and focus on data collection in parallel 
(figure 2). The simultaneous data collection was also 
chosen for pragmatic purposes, making the most of 
participant contact, given the long distances people trav-
elled to take part.
The quantitative data will be compared by age-matched 
siblings to control confounding factors like genetics, 
sociodemographics and sociocultural factors.44 While the 
qualitative and quantitative data are analysed separately, 
the results are converged to compare and contrast find-
ings during the final interpretation. The concurrent trian-
gulation used in this study will provide an in-depth and 
comprehensive understanding of the complex phenom-
enon of HRQOL in postsurgery patients with CHD, and 
the added value of sibling comparison makes this study 
unique.
study setting and participants
This study will be conducted at The Aga Khan University 
Hospital (AKUH), which is a tertiary care private hospital 
in Karachi, Pakistan. Approximately 1400 patients 
with CHD have received surgery since the site began 
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Figure 2 Study flow diagram. Health-related quality of life (HRQOL) in surgery patients with congenital heart disease in 
Pakistan: a mixed-methods study. 
its structured paediatric cardiac surgery programme 
(2008–2015). Patients who are at least 1-year post-CHD 
surgery, with no chromosomal abnormality, are able 
to understand English and/or Urdu and are willing to 
attend a face-to-face interview will be eligible for this study. 
Patients, their age-matched siblings and parents will be 
recruited for the quantitative study, and a subsample of 
the enrolled patients and parents will be recruited for the 
qualitative interviews. One parent (either the father or 
mother) would be invited for both quantitative and qual-
itative data collection. The anticipated time for recruit-
ment is 6 months, and we will continue sampling for this 
time period even if the target sample size is reached.
Quantitative arm
The quantitative arm uses a prospective cross-sectional 
descriptive study design to compare HRQOL of postoper-
ative patients with CHD with their age-matched siblings. 
It will also identify the predictors of HRQOL.
Sample size and sampling
All surgical patients who meet the eligibility criteria (esti-
mated n=1000) will be approached. Patient report, as 
the primary focus of this study, was used for sample size 
calculation. In the absence of sample size calculations 
in previously published HRQOL CHD studies, a small 
Cohen’s d effect size45 of 0.2 between CHD and their 
age-matched sibling, a power of 0.8 and a probability of 
0.05 was considered. Sample size was calculated on the 
basis of 11 predictors to be examined, which suggested a 
minimum sample size of 95 per group.46 While we hope to 
see effect sizes that suggest clinically meaningful changes, 
we have powered our study to detect small effect sizes. 
This is because, even when the magnitude of a change in 
QOL is small, it may be experienced as important by the 
patient.47
A convenience sample of patients, their age-matched 
siblings and parents will be recruited from the study 
setting. Though the use of age-matched siblings can 
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control a number of confounding factors that could 
potentially impact the study findings, it may be viewed 
by some as a limitation, with criticism of overmatching 
leading to sampling bias.44 In addition, there could be 
other impacts of CHD diagnosis and treatment on the 
entire family. One option is to recruit controls from a 
larger community, representative of the general popu-
lation. There are, however, reasons for our age-matched 
sibling approach. Many of the patients being recruited 
will belong to periurban slums, and these communities 
are diverse ethnically, economically and socially.48 Fami-
lies living in the same neighbourhood may still have 
different sociodemographic experiences.49 Thus, use of 
unrelated controls in a country like Pakistan may actually 
defeat the purpose of removing the sociodemographic 
confounders. Based on this, we choose to select sibling 
controls. Our choice is further directed by the financial 
and time constraints of recruiting an unrelated sample: 
based on our clinical experience, siblings frequently 
attend clinics with patients with CHD. A paired, matched 
analysis and conditional logistic regression will be used to 
control this potential threat to external validity.50
Eligible patients and their addresses will be identified 
through the hospital’s patient database. The primary 
physician of the eligible patients will be informed about 
this study, and a study information letter will be sent to 
the eligible patients and their parents (if age less than 
18 years) or to patients alone (18 years and above). The 
letter will invite potential participants to call the research 
team on the telephone numbers provided if they are 
interested in taking part in the study. A face-to-face inter-
view time will then be scheduled. Additionally, potential 
patient and/or parent participants will be approached 
in the hospital’s outpatient paediatric cardiology clinic 
and provided with information regarding the study and 
allowed time to consider this. An assent will be obtained 
from the patients (5–18 years) in addition to an informed 
consent from parents and from patients (>18 years). 
Potential participants will be assured that they are not 
obliged to participate. In addition, if they participate, 
they may withdraw their participation or their data at any 
time without giving a reason, and this will not affect their 
medical treatment or relationship with hospital staff.
Data collection
HRQOL data will be collected using questionnaires. 
Overall HRQOL will be assessed using the PedsQL 4.0 
Generic Core Scale. This scale has 23 items and includes 
domains for physical (8 items), emotional (5 items), 
social (5 items) and school (5 items) functioning. The 
cognitive domain will be assessed by PedsQL Cognitive 
Functioning Scale, which has six items.
The PedsQL 3.0 Cardiac Module will also be used to 
identify HRQOL specific to the cardiac problem. It is a 
27-item scale that focuses on the domains of heart problems 
(7 items), treatment (5 items), perceived physical appear-
ance (3 items), treatment anxiety (4 items), cognitive prob-
lems (5 items) and communication (3 items).
Both the questionnaires have been widely used in 
patients with CHD15 21–23 51–54 and other health prob-
lems55 56 and have well-established reliability.56 57 They 
are available for populations of different ages as well as 
their parents/proxy for young children (5–7 years), chil-
dren (8–12 years), teenagers (13–18 years), young adults 
(18–25 years) and adults (>26 years). There is also a 
proxy/parent version only for toddlers (2–4 years) given 
developmental limitations on self-report for children 
younger than 5 years of age. The questionnaires have 
very similar response items and scoring. Permission to 
use the questionnaires has been obtained from the Mapi 
Research Trust. Questionnaires have been translated to 
Urdu, which is the local language spoken in Pakistan, and 
back translated into English by a qualified translator to 
verify the translation credibility.
These questionnaires capture patient experiences for 
the last month. Both patients and parents will be asked 
to rate their HRQOL from 0 to 4 with 0 being ‘never 
a problem’ and 4 being ‘almost always a problem’. 
Responses will be reverse scored and linearly trans-
formed to 0–100 with the higher the score indicating 
better HRQOL. If more than 50% of the items in the 
scale are missing, the scale scores will be considered as 
missing data. The Psychosocial Health Summary Score 
will be calculated by adding the sum of the items over 
the number of items answered in the Emotional, Social 
and School Functioning Scales. A mean score of the 
individual domains will be calculated by adding the 
sum of the items over the number of items answered. 
The total score will be the sum of all the items over the 
number of items answered on all scales.
Sociodemographic data will be collected from patients, 
parents and siblings to characterise the sample’s current 
age, gender, socioeconomic background, educational 
status, occupation and family structure. In addition, 
patients will be asked for their current cardiac medica-
tion details (if any) and New York Heart Association func-
tional class, which is a validated tool widely used both 
in research and clinical settings to assess the functional 
status of cardiac patients.23
Patients’ clinical and surgical data will be retrieved 
from their medical files. It will include CHD diagnosis, 
age at diagnosis and surgery, surgical procedure, number 
of surgical procedures, cardiopulmonary bypass time and 
length of stay. In addition, the CHD surgical procedure 
will be assigned a Risk Adjustment for Congenital Heart 
Surgery (RACHS-1) score to identify the inpatient surgical 
mortality risk for the cardiac surgery performed.37 58–60
Data analysis
Data will be described using means, standard deviation 
(SD) and frequency and numbers according to the level 
of the variable for the demographic, clinical and surgical 
indicators. Adjusted mean differences will be reported for 
HRQOL between the person with CHD and their matched 
siblings to control for the confounders. A p Value of 0.05 
will be considered as significant. The cut-offs for PedsQL 
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Health related quality of life in patients with 
congenital heart disease surgery in Pakistan: 
qualitative interview guide
For patients
1. In your view, what is quality of life?
2. How do you see your disease, that is, congenital heart disease and 
surgery?
3. How does the community and society view your congenital heart 
disease and surgery?
4. What is the most disturbing or bothersome aspect of your surgery?
5. How do you deal with these issues and problems?
6. What are some of the concerns that are very important for you to 
discuss for your future years?
7. What do you think are the needs of patients with congenital heart 
disease with surgery and what would you like to suggest to the 
healthcare professionals to address those needs?
For parents
1. In your view, what is quality of life for your child?
2. How do you see your child’s disease, that is, congenital heart 
disease and surgery?
3. How does the community and society view your child’s congenital 
heart disease and surgery?
4. What is the most disturbing or bothersome aspect of your child’s 
surgery?
5. How do you/your child deal with these issues and problems?
6. What are some of the concerns that are very important for you to 
discuss for your child’s future years?
7. What do you think are the needs of patients with congenital heart 
disease with surgery and what would you like to suggest to the 
healthcare professionals to address those needs?
HRQOL scores reported in the literature are from HIC, 
which may not be applicable to LMIC settings. There-
fore, the study would consider 1 SD below the popula-
tion mean as a clinically meaningful cut-off for lower 
HRQOL as has been suggested by Varni et al61 and used by 
Uzark et al.52 Comparisons will also be made between 
patient and parents and between different CHD diag-
noses. For the cardiac module, comparison will only be 
made between different CHD diagnoses.
Multiple regression analysis will be used to create models 
for total HRQOL, cardiac specific HRQOL and cognitive 
function. As identified in the literature,13 18 22 25 62 the 
variables used in the analyses will include gender, socio-
economic background, parental education, family struc-
ture, cardiac lesion, age at surgery, number of surgeries, 
cardiopulmonary bypass time, RACHS scale, length of 
stay and current cardiac medications. The model signif-
icance is defined as p<0.05.
Qualitative arm
Qualitative data on health-related experiences will be 
collected on a subsample of surgical patients with CHD 
and their parents, drawn from the sample in the quanti-
tative arm.
Sample size and sampling
Stratified purposive sampling63 by age group will guide 
recruitment of participants. A minimum of 5–7 patients 
from each age group (13–18 years, 19–25 years, 25+ years) 
and parents of patients from each age group (1–4 years, 
5–12 years, 13–18 years) will be invited to participate in 
the qualitative arm of the study. Final numbers will be 
guided by a process of data saturation where major themes 
are richly described and there are no new themes devel-
oping. We would further enhance credibility of the qual-
itative data by participation equity for patients by gender, 
age and type of surgery. An additional written informed 
consent will be obtained for all individuals participating 
in the interviews.
Data collection
Qualitative data will be collected using individual inter-
views based on a semistructured interview guide. This 
guide has been designed based on the literature and in 
discussion with experts in this field, that is, a paediatric 
cardiologist (BSH), two nurse academics with research 
expertise in Cardiology (RG) (JG) and a PhD Student 
(LAL) who is also an experienced specialist nurse in 
paediatric cardiology. Topics addressed during the inter-
view include the patient/parent’s perception of HRQOL 
related to CHD surgery, identification of the domains of 
HRQOL that are most important to them during recovery, 
the areas where the impact of the CHD surgery has been 
most and least beneficial, the problems/challenges faced 
and their perceived needs for the future (box). The semi-
structured interview guide is translated in Urdu and back 
translated in English by a second researcher to verify the 
translation credibility. The interviews will be conducted 
by a single researcher (LAL), trained in qualitative tech-
niques, in a dedicated quiet room at the study setting. The 
interviews will be conducted in English or Urdu based on 
the participants’ preference and will be audio-recorded 
for accuracy. Interviews will be transcribed verbatim in 
the language in which they were recorded. Interview tran-
scripts transcribed in Urdu will then be translated into 
English for analysis.
Data analysis plan
Interview data will be analysed using directed content 
analysis64 65 guided by the Wilson-Cleary theoretical 
model of HRQOL26 (figure 1). In directed content anal-
ysis, the initial coding is guided by an existing theory or 
research findings. As researchers read and reread the 
data, their understandings are grouped under elements 
of the theoretical framework and are interpreted against 
the researchers’ understandings of the social, cultural, 
clinical and demographic profile of the participants, to 
arrive at a description of the participants’ experience of 
the phenomenon. Two members from the research team 
will review the transcripts and collaborate on analysis to 
enhance the credibility of findings. Rigour of the quali-
tative component will be enhanced by the application of 
Elo et al’s ‘Checklist to Improve the Trustworthiness of a 
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Content Analysis Study’ to the preparation, organisation 
and reporting phases.66
Ethics and dissemination
This study has received approval from the ethics review 
committee of the study setting. Informed consent will be 
obtained from patients and their parents both orally and 
in writing, and participants will be offered a choice to 
receive that information in English or Urdu. Assent will 
also be obtained from patients’ of age 5–18 years. Patients 
and/or their parents will be provided with transportation 
costs through the support of the paediatric department 
of AKUH.
While the risks associated with this study are negligible, 
it is possible that a participant may become distressed 
while telling their story. In this instance, we would follow 
the participant distress protocol developed for this study. 
Data confidentiality and archiving will be maintained 
as per Good Clinical Practice Guidelines.67 Study find-
ings will be disseminated through peer-reviewed publi-
cations and presentation at national and international 
conferences.
Anticipated challenges
We anticipate certain challenges while conducting this 
study. Approaching the patients by phone or mail could 
be challenging due to changes in contact details that 
might not have been updated in the hospital database. 
In addition, recruitment directly from the hospital clinic 
may be difficult due to irregular clinic presentations. 
Transcribing the qualitative interviews into Urdu and 
then arranging their translation and back-translation 
provides an added layer of complexity. However, initial 
translation from Urdu to English will be conducted by 
one bilingual researcher (LAL) to avoid interpretation 
bias. The English version of key qualitative data will 
then be given to a second Urdu-speaking researcher and 
cardiology physician (BSH) to translate back to Urdu. 
The two Urdu texts will then be checked for congruence 
of meaning and any differences carefully considered and 
negotiated for the most accurate English equivalent.68 
Using the descriptive analytical method of content 
analysis, we will keep the level of interpretation very 
‘close to the data’,69 further reducing the potential for 
misinterpretation.
Our strong clinical connections to the study setting, 
track of patients at the outpatient clinics and outreach 
trips to more remote referral areas will inform our inter-
pretation of qualitative data and will assist in maximum 
patient recruitment.
Despite these study challenges, we look forward to 
the findings of this study that will provide much-needed 
understanding of the needs of patients and families who 
experience CHD and surgery within a LMIC. This will 
allow a more nuanced development of interventions and 
resources to meet these particular needs.
conclusIon
This study aims to determine the HRQOL of people 
who have surgery to address CHD and to identify asso-
ciated HRQOL predictors in Pakistan. Considering 
the differences in sociodemographic variables and the 
surgical outcomes between HIC and LMIC, it is likely 
that HRQOL may differ between countries and that 
differences may be influenced by individual, social and 
cultural contexts. HRQOL of surgical patients with CHD 
will be assessed as self-report and will be compared with 
their age-matched healthy siblings and their parents’ 
assessment. Triangulation of data will add richness and 
depth to our understanding of the factors and processes 
related to HRQOL following CHD surgery. This may 
provide a focus for CHD care planning and resource 
allocation in the LMIC of Pakistan.
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